USNA

USNA

USD

USANA Health Sciences Inc. Common Stock

$27.180+0.180 (0.667%)

实时价格

Consumer Defensive
包装食品
美国

价格图表

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$27.000

最高价

$27.190

最低价

$26.460

成交量

0.03M

公司基本面

市值

512.6M

所属行业

包装食品

国家/地区

United States

交易统计

平均成交量

0.22M

交易所

NYQ

货币

USD

52周价格范围

最低价 $23.1当前价 $27.180最高价 $49.78

AI分析报告

最后更新: 2025年4月23日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

USNA: USANA Health Sciences Inc. Common Stock - Analyzing Recent Moves & What Might Come Next

Stock Symbol: USNA Generate Date: 2025-04-23 13:48:15

Alright, let's break down what's been going on with USANA Health Sciences stock lately. We'll look at the latest news, check out how the price has been moving, and see what some automated predictions are saying.

Recent News Buzz

The big news hitting the wires just yesterday (April 22nd) was USANA's report on their first quarter results for 2025. The headline mentioned net sales hitting $250 million and, importantly, that the company is sticking with its full-year outlook. Now, the news snippet we have doesn't give us all the details like profit or earnings per share, but reiterating the full-year outlook often suggests management feels reasonably confident about where things are headed, even if the sales figure itself needs more context.

Before that, back on April 14th, there was a positive piece about a clinical study showing one of their skincare products, Celavive's Resurfacing Serum, improved skin appearance pretty quickly. That's good news for that specific product line, showing it's backed by some science, which can help sales.

So, the vibe from the news is primarily focused on the recent earnings report. Sticking to the full-year outlook after Q1 is generally seen as a steady sign, not necessarily spectacular, but not a red flag either, based just on the headline. The skincare study is a nice little bonus.

Price Check

Looking at the stock's journey over the last month or so, it's been a bit of a bumpy ride, mostly trending downwards. Back in late March, shares were trading in the $27-$28 range. Then, through early April, the price slid quite a bit, dipping down towards the $24-$25 area.

But then came today, April 23rd. Wow, what a jump! The stock opened significantly higher than yesterday's close and has climbed sharply, hitting highs around $28.19. This kind of move right after an earnings announcement usually means the market liked something in that report, even if the news snippet didn't spell it all out. The volume today isn't huge yet compared to the average, but the price reaction is undeniable.

Now, the AI prediction for today said 0.00% change, which clearly didn't capture this post-earnings surge at all. For tomorrow, the AI actually predicts a dip of about 2.86%, followed by a small gain the day after (+0.96%). This suggests the AI thinks today's big move might not hold entirely.

Outlook & Ideas

Putting it all together, the dramatic price jump today, right after the earnings report, seems to be the dominant factor right now. Despite the stock's recent slide leading up to the report and the AI predicting a dip after today, the market's immediate reaction is strongly positive. This suggests the Q1 results or the reiterated outlook were better received than the prior price trend might have indicated.

So, the apparent near-term leaning, based purely on today's price action tied to the earnings news, seems bullish. The stock is showing strong momentum right now.

What might someone consider doing? Well, the big move has already happened today. Trying to jump in right at the peak of a sudden surge can be risky. One possible strategy could be to watch if this momentum continues or if the stock consolidates (trades sideways) after this initial reaction. If it pulls back slightly but holds above a key level like today's open ($25.50) or even yesterday's close ($24.24), that might be seen by some as a potential entry point if they believe the positive reaction will last.

For managing risk, setting a stop-loss is always smart. A potential level to consider for a stop-loss could be below today's open ($25.50) or perhaps below yesterday's close ($24.24). If the price falls back below those levels, it could signal that today's jump was just a temporary reaction. As for taking profits, the AI predicts a dip tomorrow, which could suggest a very short-term trader might look to lock in gains quickly, but predicting the exact top is impossible. Watching for signs of the momentum slowing down or hitting resistance levels would be key.

Company Context

Just remember, USANA is in the Packaged Foods/Consumer Defensive sector. This means their business is generally less sensitive to economic ups and downs compared to, say, tech or retail. However, they operate with a direct selling model, which has its own unique dynamics and challenges. They are also a relatively small company with a market cap around $531 million, which can sometimes mean more volatile price swings compared to larger companies. The company details also point out some fundamental challenges like negative revenue growth and high debt, which are worth keeping in mind beyond the short-term price action driven by earnings.


Disclaimer: This analysis is for informational purposes only and is based solely on the provided data. It is not financial advice. Stock investing involves risk, and you could lose money. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

相关新闻

BusinessWire

USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook

USANA Health Sciences, Inc. (NYSE:USNA) today announced financial results for its fiscal first quarter ended March 29, 2025. Key Financial Results First Quarter 2025 vs. First Quarter 2024 Net sales of $250 million

查看更多
USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook
PR Newswire

Clinical Study Shows USANA Celavive's Resurfacing Serum to Improve Appearance of Skin in Just Two Weeks

USANA Health Sciences, Inc., a global leader in cellular nutrition, recently conducted a clinical study on its Celavive Resurfacing Serum to evaluate ...

查看更多
Clinical Study Shows USANA Celavive's Resurfacing Serum to Improve Appearance of Skin in Just Two Weeks
BusinessWire

USANA Schedules First Quarter 2025 Earnings Release and Conference Call

USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2025 results will be released after the close of market on Tuesday, April 22, 2025. Shortly following the issuance of the Company's earnings

查看更多
USANA Schedules First Quarter 2025 Earnings Release and Conference Call

AI预测Beta

AI建议

看跌

更新于: 2025年4月28日 02:18

看跌中性看涨

59.6% 置信度

风险与交易

风险等级3/5
中风险
适合于
价值
交易指南

入场点

$26.86

止盈点

$27.72

止损点

$25.66

关键因素

PDI 14.9高于MDI 10.2,且ADX 15.5,表明看涨趋势
当前价格非常接近支撑水平$26.96,表明有强烈的买入机会
交易量是平均值的10.4倍(2,557),表明极强的买入压力
MACD 0.0305低于信号线0.0332,表明看跌交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。